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The mosaic pattern of p16INK4a ex-
pression in acquired nevi is reminiscent
of the heterogeneity of B-RAF mutations
found in human nevi (Lin et al., 2009).
It remains to be determined whether
the mutant B-RAF is coexpressed with
p16INK4a or if activated B-RAF and
loss of p16INK4a contribute separately
to the clonal expansion of melanocytes.
Alternatively, activated B-RAF and
p16INK4a deficiency may co-exist in
a small percentage of nevus cells to
enhance melanocyte proliferation and
drive neoplastic transformation. The
absence of a mutant-specific B-RAF
antibody has so far precluded the
execution of such an analysis. It is well
established that activated B-RAF can
promote nevus formation in murine and
fish melanoma models (Patton et al.,
2005; Goel et al., 2009), and the
arrested state of nevi does not appear
to require p16INK4a (Dhomen et al.,
2009). Nevertheless, the influence of
p16INK4a loss on the development of
B-RAFV600E-induced nevi needs to be
investigated in human melanocytic
tumors. This is particularly relevant as
p16INK4a loss regulates the penetrance
and latency of B-RAF-induced murine
melanomas (Dhomen et al., 2009).
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TO THE EDITOR
UVR is the main factor in skin cancer
(Bath-Hextall et al., 2007). Low-dose
UVB (280–320 nm) radiation is suffi-
cient for cutaneous photosynthesis of
previtamin D from 7-dehydrocholes-
terol (Tian and Holick, 1999). Some
epidemiologic studies suggest that a
poor vitamin D status increases the risk
for several cancers and autoimmune
diseases (Holick, 2008). Vitamin D
activity in peripheral tissues, such asAbbreviations: IVD, integrated density value; MED, minimal erythema dose; VDR, vitamin D receptor
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the epidermis, is mediated by the
vitamin D receptor (VDR), which is
also expressed on various malignant
cells including basal cell carcinoma
and squamous cell carcinoma. The
binding of 1,25-dihydroxyvitamin D to
the VDR results in proapoptotic and
anticancer effects in different types of
cancers, modulating over 60 genes with
prodifferentiating, antiproliferative, and
antimetastatic effects on cells (Bikle,
2008; Raimondi et al., 2009).
Although there are many studies on
the effect of UVB on vitamin D synthe-
sis, there are few data on its impact
on VDR expression in healthy skin
(Mallbris et al., 2005; Hong et al.,
2008). To date, most information on
UVR effects on human skin has been
obtained from experiments with
single, often erythemogenic, exposures
(Narbutt et al., 2007). These protocols
do not mimic natural conditions, as
the majority of people are exposed to
daily suberythemal UVR doses, with
occasional sunburning doses, espe-
cially in summer months.
In our previous studies, we demon-
strated that repeated suberythemal UVB
resulted in limited photoprotection
against the effects of a later erythemal
challenge dose of UVB, in which the
end points were cytokine expression
and DNA photodamage (Narbutt et al.,
2007). The aim of the present study was
to assess photoadaptation and photo-
protection, using a protocol similar to
that described above, with VDR protein
expression as the end point (Figure 1).
The study, carried out according to
the declaration of Helsinki, included 46
healthy subjects (26 female, 20 male,
mean age 24.1±3.4 SD years) of either
phototype II (n¼19) or III (n¼27). Each
gave informed consent after approval
by the Ethics Committee of the Medical
University of Lodz. Subjects exposed
to high doses of sunlight or sun-
lamps within 2 months before the study
were excluded. Irradiation protocols
have been described by Narbutt et al.
(2007). The UVR source contained
TL12 tubes (Philips, Eindhoven, The
Netherlands) emitting 58.6% UVB and
41.4% UVA; thus, the vast majority
of the erythemally effective energy was
UVB. Volunteers were divided into
four groups (see Table 1): (A) 24 non-
irradiated controls, (B) 6 irradiated
with a single 3 minimal erythema dose
(MED) exposure on the left buttock
(1010 cm2), (C) 8 exposed to 0.7
MED whole-body exposure for 10 con-
secutive days, and (D) 8 treated as
in group C, but followed by a single
3 MED exposure 24 hours later to the
left buttock (10 10 cm2). In all cases,
the 0.7 and 3 MED exposures were
individualized. The mean MED (lower
back) of all volunteers was 0.16 J cm2
(±0.02 J cm2 SD). A single 4 mm skin
biopsy (left buttock) was taken from
each volunteer 24 hours after the final
exposure for the assessment of VDR
protein expression. Biopsies were homo-
genized and sonicated, and 50mg crude
cell lysates were separated on 10% SDS-
PAGE gels before transfer to polyvinyl-
idene difluoride membranes (Millipore,
Billerica, MA). Total protein of the cell
lysate was assayed by bicinchoninic
acid reagent (Pierce, Rockford, IL). The
mean concentration of total protein per
biopsy was 322.9mg (±47.7 SD) using
BSA as a standard (Zebrowska et al.,
2009).
The expression of VDR was assessed
with a mouse anti-human VDR anti-
body (1:200 dilution, both Santa
Cruz Biotechnology, Santa Cruz, CA),
followed by application of horseradish
peroxidase-conjugated donkey anti-
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Figure 1. Vitamin D receptor expression. (a) Typical vitamin D receptor (VDR) western blots from
unirradiated control and irradiated groups. The lanes represent different individuals. (b) Densitometric
quantification of VDR western blots from unirradiated control and irradiated groups. Each data point
represents one biopsy from one individual and horizontal bars represent median values. MED, minimal
erythema dose.
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UK). The blot was developed using
ECL plus Western Blotting Detection
Reagents (GE Healthcare, Chalfont
St Giles, UK). The ChemiImager System
(Cell Biosciences, Santa Clara, CA)
was used for densitometric analysis
of bands, and results were expressed
as integrated density values (IDVs) as
shown in Table 1.
The highest VDR expression was
observed in the group irradiated with
a single 3 MED exposure (group B:
median 1.08106 IDV) and the lowest
was observed in the group with sub-
erythemal exposure followed by 3 MED
(group D; median 0.29 106 IDV).
VDR expression was significantly
higher in the 3 MED UVB-irradiated
group (group B) when compared with
the unirradiated control (median
1.08106 IDV vs. median 0.44106
IDV, respectively; P¼0.03). In the
group that was preirradiated and then
exposed to 3 MED, the VDR expression
was lower than that in the group
exposed to 3 MED only (median
0.29106 IDV vs. median 1.08106
IDV, respectively; P¼ 0.01). No
changes in VDR expression were found
in the group exposed for 10 consecutive
days to suberythemal UVB (median
0.42106 IDV) when compared with
either control group A or group D (10
UVBþ3 MED; P¼0.09).
In our study, we aimed to explore
the relevance of repeated, suberythe-
mal and acute UVB doses on VDR
protein expression in healthy skin using
UVB-irradiating protocols that may
mimic natural solar exposure. Our data
support and extend studies on UVB-
induced expression of VDR mRNA.
Mallbris et al. (2005) showed that
1 MED UVB significantly upregulated
VDR mRNA expression at 24–28 hours
in healthy normal skin. Hong et al.
(2008) showed that 0.5 MED UVB for
three consecutive days significantly
increased mRNA VDR expression in
hairless mice. Our irradiation protocol
demonstrates that the effects of an acute
highly erythemal UVB dose are abro-
gated by previous exposure to daily
suberythemal UVB for at least 10 days.
The total suberythemal exposure was
7 MED, or more than twice the 3 MED
challenge dose, which on its own
induced VDR protein expression. Thus,
the suberythemal effects on VDR
expression are not cumulative as is the
case with some suberythemal expo-
sures (Seite´ et al., 2010); indeed, levels
were the same as controls.
Skin keratinocytes have the unique
property of being the primary source of
previtamin D and having the enzymatic
machinery to synthesize biologically
active vitamin D (Bikle, 2010). It has
been suggested that lack of vitamin D
toxicity under chronic/high-dose UVB
exposure may result from homeo-
static mechanisms via the formation
of inactive photometabolites such as
tachysterol or lumisterol from previta-
min D (Tian and Holick, 1999). We
hypothesize that a cutaneous homeo-
static photomechanism regulates UVB-
induced VDR expression. The lack of a
cumulative effect from repeated sub-
erythemal exposure (groups A vs. C)
and a diminished response to 3 MED in
preexposed (group D) compared with
naı¨ve skin (group B) are indicative
of photoadaptation. This can perhaps
be considered as molecular photo-
protection.
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